Department of Diagnostical and Interventional Radiology, Heidelberg University Hospital, Heidelberg, Germany.
Department of Radiology, First Moscow City Hospital, Moscow, Russia.
Sci Rep. 2021 Jan 19;11(1):1800. doi: 10.1038/s41598-021-81322-4.
Accuracy for computed tomography (CT) diagnosis of extrapancreatic perineural invasion (EPNI) in pancreatic ductal adenocarcinoma (PDAC), which is a significant cause of recurrence, has not been established. The aim of the study was to evaluate the diagnostic accuracy of CT in detecting EPNI preoperatively in resectable PDAC of the pancreatic head. Retrospective study design was approved by institutional review board. Preoperative CT-series of 46 patients with resectable PDAC were evaluated by two independent observers. Plexus Pancreaticus Capitalis-II (PPC-II) was assessed as this area is more susceptible for EPNI. All patients underwent surgery with dedicated histopathology, which served as the reference standard. Histologically EPNI was confirmed in 63.1%. Sensitivity of MDCT was 93.1% (95% confidence interval (CI) 77.23% to 99.15%), specificity 64.7% (95% CI 38.33% to 85.79%) with area under the curve (AUC) 0.789 for the first observer. Positive predictive value (PPV) was 81.82% (95% CI 70.12% to 89.62%), negative predictive value (NPV-84.62% (95% CI 57.98% to 95.64%) with diagnostic accuracy of 82.61% (95% CI 68.58% to 92.18%). Interobserver agreement showed k-value of 0.893 ([Formula: see text]), which represents very good agreement between observers. Median actual survival in patients without EPNI was 30 months (95% CI 18.284-41.716), in patients with EPNI-13 months (95% CI 12.115-13.885). CT provides sufficient diagnostic information to detect PPC-II invasion in patients with resectable PDAC of the pancreatic head. Preoperative detection of EPNI might be an additional argument to perform neoadjuvant chemotherapy in patients with resectable PDAC. It should be included in preoperative evaluation form of CT-findings.
计算机断层扫描(CT)对胰腺导管腺癌(PDAC)胰外神经周围侵犯(EPNI)的诊断准确性尚未确定,EPNI 是复发的重要原因。本研究旨在评估 CT 术前诊断胰头可切除 PDAC 中 EPNI 的诊断准确性。机构审查委员会批准了回顾性研究设计。由两名独立观察者评估 46 例可切除 PDAC 患者的术前 CT 系列。评估了 Plexus Pancreaticus Capitalis-II(PPC-II),因为该区域更容易发生 EPNI。所有患者均接受了专门的组织病理学检查,作为参考标准。组织学上证实有 63.1%的患者存在 EPNI。MDCT 的敏感度为 93.1%(95%置信区间 77.23%至 99.15%),特异度为 64.7%(95%置信区间 38.33%至 85.79%),第一观察者的曲线下面积(AUC)为 0.789。阳性预测值(PPV)为 81.82%(95%置信区间 70.12%至 89.62%),阴性预测值(NPV)为 84.62%(95%置信区间 57.98%至 95.64%),诊断准确性为 82.61%(95%置信区间 68.58%至 92.18%)。观察者间的一致性显示 k 值为 0.893([公式:见正文]),表示观察者之间存在非常好的一致性。无 EPNI 的患者的中位实际生存率为 30 个月(95%置信区间 18.284-41.716),有 EPNI 的患者为 13 个月(95%置信区间 12.115-13.885)。CT 可提供足够的诊断信息来检测胰头可切除 PDAC 患者的 PPC-II 侵犯。术前检测 EPNI 可能是对可切除 PDAC 患者进行新辅助化疗的另一个论据。它应该包含在术前 CT 检查结果的评估表中。